期刊名称：INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The International Journal of Oral & Maxillofacial Surgery is one of the leading journals in oral & maxillofacial surgery in the world. The Journal publishes papers of the highest scientific merit and widest possible scope on work in oral and maxillofacial surgery and supporting specialties. It had an Impact Factor of 0.932 in 2000, considerably ahead of its closest rivals.
The Journal is divided into sections, ensuring every aspect of oral and maxillofacial surgery is covered fully through a range of invited review articles, leading clinical and research articles, technical notes, abstracts, case reports and others. The sections include:
- Congenital and craniofacial deformities
- Cosmetic facial surgery
- Orthognathic surgery/trauma/TMJ disorders
- Head and neck oncology
- Reconstructive pre-prosthetic surgery/implantology
- Clinical pathology/dentoalveolar surgery
- Medicine/pharmacology
- Research and emerging technologies
- Evidence-based therapy
Speedy reviewing and electronic processing means that articles are published as rapidly as possible. Accepted articles are published rapidly online first, and the web site, www.ijoms.com is an important resource for the field.
Indexed and Abstracted in:
Biological Abstracts/BIOSIS, Current Contents: Clinical Medicine, EMBASE/Excerpta Medica, Index Medicus/MEDLINE, Medical Documentation Service, Research Alert, Science Citation Index, SciSearch
Instructions to Authors
Pitfalls in the treatment of
delayed lymph-node metastases
after control of small tongue
carcinomas
H|roshi Kurita,
KenJi Kurashlna, Toshikazu Minemura,
Akira Kotani
Department of Dentistry and Oral Surgery,
Shinshu University School of Medicine,
Matsumoto, Japan
H. Kurita, K. Kurashina, T. Minemura, A. Kotani: Pitfalls in the treatment of
delayed lymph-node metastases after control of small tongue carcinomas. Int. J.
Oral Maxillofac. Surg. 1995; 24: 356-360. 9 Munksgaard, 1995
Abstract. Between 1985 and 1992, 13 patients were treated for delayed lymphnode
metastases that developed after obtaining control of primary lesions of
the tongue. These lesions were treated primarily by radiotherapy or surgical resection;
cervical metastases were treated mainly by delayed radical neck dissection
(RND). Seven of the 13 patients survived with no evidence of recurrence. The
other six patients developed tumors in the neck, and five of these patients died due
to uncontrollable disease. In all but one patient, recurrence appeared between the
site of the primary lesion and the region of RND, the oral floor and/or the parapharyngeal
space. None of the patients with recurrence received radiotherapy in
the area between the primary lesion and the site of RND. In contrast, there was
no recurrence in patients who received external irradiation to the primary lesion
and upper cervical lymph nodes. This review emphasizes the need to direct more
attention to the area between the site of the primary lesion and the regional
lymph nodes in patients receiving treatment for delayed metastases associated
with small carcinomas of the tongue.
Key words: tongue; carcinoma; lymph-node
metastasis; radical neck dissection;
radiotherapy,
Accepted for publication 15 June 1995
Because of the rich lymphatic drainage
of the tongue, occult lymph-node metastases
occur in 23% to 66% of patients
with small tongue carcinomas (stages I
or II), and the salvage rate in these patients
is poor 3,6,8,12,17J8.
Stage I or early stage II primary tumors
of the tongue often can be treated
with radioactive implants. Delayed
lymph-node metastases are frequently
treated by radical neck dissection
(RND), independently of the primary
lesion. However, little attention has
been paid to the area between the primary
lesion in the tongue and the regional
lymph nodes, the site of the local
lymphatic drainage system ("untreated
area", Fig. 1). We previously reported
B Primary
[] Area of
conventional RND
I Treated primary site
Lymphatic flow
Fig. 1. Schematic representation of treated primary site, surgical area of conventional radical
neck dissection (RND), and regional lymphatic flow. When primary lesion and neck metastases
are treated separately, area between them remains "untreated".
Instructions to Authors
sdarticle1.pdf
0901-5027.pdf
Editorial Board
Editor-in-Chief:
Prof Piet E. Haers, Post Graduate Medical School, University of Surrey, Stirling House, Surrey Research Park, Guildford, Surrey , GU1 2AP, UK, Tel: +44 (0 1483 555 936, Fax: +44 (0)1483 569 594, Email: editorialoffice.ijoms@surrey.ac.uk,
Honorary Editor-in-Chief:
Prof Paul J. W. Stoelinga, Nijmegen, The Netherlands
Assistant Editor-in-Chief:
Prof Lim K Cheung, Hong Kong
Dr David H Perrott, Salinas, USA
Section 1 - Congenital craniofacial deformities:
Prof Leonard B Kaban, (Chairman) Boston, USA
Prof Michael Cohen, Halifax, Canada
Dr David S Precious, Halifax, Canada
Section 2 - Cosmetic facial surgery:
Dr Maurice Mommaerts, (Chairman) Bruges, Belgium
Prof R B Drommer, Heidelberg, Germany
Dr Johannes F Honig, Gottingen, Germany
Section 3 - Orthognathic surgery/trauma/TMJ:
Dr Joseph F Piecuch, (Chairman) Avon, USA
Dr Thomas W Braun, Pittsburgh, USA
Prof Lim K Cheung, Hong Kong
Dr Lambert de Bont, Groningen, The Netherlands
Dr Uwe Eckelt, Dresden, Germany
Prof Edward Ellis, Dallas, USA
Prof Klaus L Gerlach, Magdeburg, Germany
Dr Andrew Heggie, Melbourne, Australia
Prof Masatoshi Ohnishi, Yamanashi, Japan
Section 4 - Head and neck oncology:
Dr James Brown, (Chairman) Liverpool, UK
Prof Eric Fossion, Antwerp, Belgium
Prof Berthold Hell, Berlin, Germany
Prof Gernot Jundt, Basel, Switzerland
Prof John D Langdon, London, UK
Prof H-R Metelmann, Greifswald, Germany
Dr Robert A Ord, Baltimore, USA
Section 5 - Reconstructive pre-prosthetic/dentoalveolar:
Dr John I Cawood, (Chairman) Chester, UK
Dr Michael Block, New Orleans, USA
Dr Soren Hillerup, Copenhagen, Denmark
Dr Peter K Moy, Los Angeles, USA
Dr Peter D Waite, Birmingham, USA
Section 6 - Clinical pathology:
Dr Nabil Samman, (Chairman) Hong Kong
Prof Arne Burkhardt, Reutlingen, Germany
Dr Etienne Piette, Namur, Belgium
Dr M Anthony Pogrel, San Francisco, USA
Prof Joseph Regezi, San Francisco, USA
Prof John Scott, Liverpool, UK
Prof Piet J Slootweg, Utrecht, The Netherlands
Dr Julia Woolgar, Liverpool, UK
Section 7 - Medicine/Pharmacology,
Prof Stephen R Porter, (Chairman) London, UK
Dr Joel B Epstein, Vancouver, Canada
Prof Larry J Peterson, Columbus, USA
Section 8 - Research and emerging technologies:
Prof Stephen E Feinberg, (Chairman) Ann Arbor, USA
Dr Hiroki Bukawa, Chiba, Japan
Dr Jeffrey Hollinger, Pittsburg, USA
Dr John P Kelly, New Hyde Park, USA
Dr Paul Krebsbach, Ann Arbor, USA
Dr Henning Schliephake, Gottingen, Germany
Dr Riitta Suuronen, Helsinki, Finland
Dr Franz Weber, Zurich, Switzerland
Section 9 - Evidence-based therapy:
Dr David H Perrott, (Chairman) Salinas, USA
Prof Alastair Goss, Adelaide, Australia
Prof Peter Ward-Booth, East Grinstead, UK
Abstract Editors:
Dr George Anastassov, (Russian literature) Elmhurst, USA
Prof Herve Reychler, (French literature) Brussels, Belgium
Prof Henning Schliephake, (German literature) Hannover, Germany
Dr S. Guo-Fang Shen, (Chinese literature) Shanghai, China
Professor Piet E. Haers, Editor-in-Chief, Post Graduate Medical
School, University of Surrey, Stirling House, Surrey Research Park,
Guildford, Surrey GU2 7DJ, UK. Tel: +44 (0)1483 555936; Fax:
+44 (0)1483 569594; E-mail: editorialo.ce.ijoms@ac.surrey.uk
|
